<DOC>
	<DOCNO>NCT00002060</DOCNO>
	<brief_summary>The objective determine effect Isoprinosine ( inosine pranobex ) homosexual male patient AIDS relate complex ( ARC ) delay onset AIDS . Secondly , determine effect Isoprinosine decreasing severity and/or incidence lesser opportunistic infection and/or condition associate ARC .</brief_summary>
	<brief_title>A Multi-Center Randomized Double-Blind Placebo-Controlled Study To Investigate Effect Isoprinosine Patients With AIDS Related Complex ( ARC )</brief_title>
	<detailed_description />
	<mesh_term>HIV Infections</mesh_term>
	<mesh_term>AIDS-Related Complex</mesh_term>
	<mesh_term>Inosine Pranobex</mesh_term>
	<criteria>Exclusion Criteria Concurrent Medication : Excluded : Cardiac glycoside . Patients follow exclude : AIDS . Presenting chronic candida infectioncolo/rectal , oral/pharyngeal , cutaneous ( finger/toenails ) = &gt; 3 month respond therapy . Critical illness . Hemophilia . Prior Medication : Excluded within 1 month study entry : Steroids . Cytotoxic immunosuppressive agent . Radiotherapy and/or systemic antiviral medication . Immunomodulators ( include Isoprinosine ) . Prior Treatment : Excluded within 1 month study entry : Radiotherapy . History gout , uric acid urolithiasis , uric acid nephrolithiasis , renal dysfunction . Lymphoid malignancy . Homosexual male patient AIDS relate complex ( ARC ) . Current IV drug abuse .</criteria>
	<gender>Male</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>June 1989</verification_date>
	<keyword>AIDS-Related Opportunistic Infections</keyword>
	<keyword>Inosine Pranobex</keyword>
	<keyword>Homosexuality</keyword>
	<keyword>Acquired Immunodeficiency Syndrome</keyword>
	<keyword>AIDS-Related Complex</keyword>
</DOC>